In a year marked by macroeconomic uncertainty and renewed trade tensions that have shaken the equity market, CVS Health CVS has emerged as an unexpected outperformer. After a rough 2024, marked by ...

The first quarter is in the books, and the S&P 500’s best and worst performers are a pharmacy chain and a footwear ...

The best-performing S&P 500 stocks of Q1 2025 include CVS Health, Philip Morris, Newmont, and AT&T, all outperforming amid ...

The healthcare sector, as measured by Health Care Select Sector SPDR Fund (NYSEARCA:XLV), with 12.12% weightage on the S&P 500, bagged a ... look at the sector’s performance and where its ...

CVS Health (CVS) closed at $68.07, indicating a +0.13% shift from the previous trading day. While many stocks in the S&P 500 ETF posted dismal performance in the just-concluded quarter ...

A group of S&P 500 stocks have remained resilient as tariffs and earnings concerns cause the market to drop. Future gains may be limited.

The S&P 500 added 0.5% on Wednesday, March 12, after a key inflation report showed consumer prices increased at a slower-than-expected pace last month.

While most of the market struggles, yesterday’s case in point, CVS is thriving, leading the S&P 500 with an impressive ... assessments of a stock's market performance and potential with a ...

Energy, basic materials, consumer staples, and utilities were the top sectors in the first quarter. The broader market had ...